BostonSight CEO Sara Yost Featured in Contact Lens Spectrum Industry Focus - BostonSight

$ 21.50

4.6 (300) In stock

This month, we focus on BostonSight, a non-profit organization and scleral lens manufacturer. I recently had the pleasure to speak with BostonSight President and CEO, Sara Yost. Ms. Yost, please tell us about your organization in terms of its history and direction. BostonSight is a nonprofit health-care organization based in Need-ham, MA. It was founded in 1992 with a mission to address the unmet needs of patients suffering from ocular surface disease and vision loss from corneal disease, damage, or injury. We started a small clinic to provide scleral lenses for this purpose. In 1994, we developed and manufactured the first U.S. Food and Drug Administration-approved flu-id-ventilated scleral lens for therapeutic and irregular corneal indica-tions. We hold patents in scleral lens design and manufacturing, and we also share a patent with the University of Rochester in correcting higher-order aberrations (HOAs). We wanted to share what we learned so that patients outside of our clinic could benefit. We published peer-reviewed literature. Since 2007, we have trained practitioners on our Boston PROSE treatment in tertiary eyecare centers in four countries. In 2017, we launched BostonSight Scleral with our new FitConnect platform. BostonSight Scleral is our data-driven lens based on scleral shape. It has left and right eye designs for more efficient and effective fitting. FitConnect is an all-in-one resource and practice management tool for fitting scleral lenses. Patient care and expanding global access to our innovations remains at our core. In 2018, we partnered with LV Prasad Eye Institute in Hyderabad, India, and […]